Rise in Molecular Cytogenetics Market is Expected to Reach USD 130 Billion in 2018: Transparency Market Research

ALBANY, New York, August 25, 2014 – The global Molecular cytogenetics market will be valued at US$1.9 billion in the year 2019, after growth at a CAGR of 23.4% from 2013 to 2019, according to the report by Transparency Market Research. The market was worth US$468.2 million in 2019.

The research report titled “Molecular Cytogenetics Market (Technologies: FISH and aCGH; Applications: Genetic Disorders, Cancer and Personalized Medicine) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019”, is aimed at establishing the importance of the upcoming technologies in molecular cytogenetics, namely FISH and aCGH.

For further information about the research report regarding the ToC and analysis details, please visit: http://www.transparencymarketresearch.com/molecular-diagnostics-market.html.

The report states that the array Comparative Genomic Hybridization (aCGH) market is expected to be a fast-growing sector, registering a CAGR of 20%. aCGH is a technique that utilizes a high resolution tool incorporating thousands of experiments in one array. This means that clinicians can shift from sequential diagnosis to parallel diagnosis, allowing them to conduct experiments with accurate results at one time.

The report explains that Fluorescence In Situ Hybridization (FISH) technology is attributed to interpret information at the genome level, and currently dominates the molecular cytogenetics market. Over the past decade, the FISH technology has been used to identify various diseases as well as suggest accurate treatment. The technique is being constantly improved by work in the field of bioinformatics and genomics.

According to the report, aCGH is a more accurate technique, and is expected to surpass FISH in the next few years. The increase in demand for a better cytogenetic technique should be successfully met by expansions in manufacturer product portfolios.

The report also provides an exhaustive and comparative analysis of the key players in the industry: Agilent Technologies, Inc., Abbott Laboratories, Affymetrix, Inc., Bio-Rad Laboratories, BI Biological Industries, Illumina, Inc., Cytognomix, Inc., CytoTest, Inc., Inc., Hoffmann-La Roche Ltd., Life Technologies Corporation, LEICA BIOSYSTEMS, PerkinElmer, Inc., Oxford Gene Technology, Applied Spectral Imaging, Inc., and SciGene Corporation.

The report predominantly explores the molecular cytogenetics market using three categorical segregations. On the basis of technology, the report analyzes FISH and aCGH. The various applications documented in the report include cancer, genetic disorders, personalized medicines, and others. By geography, the report focuses on North America, Europe, Asia-Pacific, and Rest of the World.

The report utilizes Porter’s Five Force Analysis to create a comparative landscape of the market from the standpoint of both buyers and suppliers, as well as threat from competitors, substitutes, and new entrants.